Abstract
The underlying mechanisms leading to stress-hyperglycemia and its association with poor outcomes in cardiac surgery patients are not well understood. We aimed to identify metabolic signatures associated with stress-hyperglycemia in patients with atherosclerotic cardiovascular disease (ASCVD) undergoing coronary artery bypass-graft (CABG) surgery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
